Table of contents


  1. HIV/AIDS: Bad laws damage HIV response
  2. UGANDA: New LGBTI clinic faces fierce government criticism
  3. UGANDA: A timeline of events affecting LGBTI
  4. ASIA: Patent protection clauses weaken ARV access
  5. SOUTH AFRICA: Activists protest as Novartis ruling approaches


HIV/AIDS: Bad laws damage HIV response
JOHANNESBURG، 10/7/2012 (IRIN) - Archaic laws that criminalize HIV transmission and same-sex relations are driving the spread of HIV, costing lives and wasting vital resources, according to a new report by the Global Commission on HIV and the Law. full report
UGANDA: New LGBTI clinic faces fierce government criticism
KAMPALA، 11/7/2012 (IRIN) - Gay rights activists have opened Uganda's first clinic for lesbian, gay, bisexual, transgender and intersex people in the capital, Kampala, where it will provide testing, counselling and treatment for HIV and other sexually transmitted infections. full report
UGANDA: A timeline of events affecting LGBTI
NAIROBI، 11/7/2012 (IRIN) - Uganda has made international headlines in recent years for its strong anti-homosexuality stance, but health experts have warned that more must be done to include LGBTI in HIV prevention services. IRIN has put together a short timeline of key events in the struggle for their inclusion. full report
ASIA: Patent protection clauses weaken ARV access
BANGKOK، 12/7/2012 (IRIN) - Pressure on developing countries to adopt clauses affecting intellectual property rights could limit access to generic antiretroviral (ARV) drugs in Asia and the Pacific, experts and activists warn. full report
SOUTH AFRICA: Activists protest as Novartis ruling approaches
CAPE TOWN، 12/7/2012 (IRIN) - At least a hundred protesters arrived at South Africa's parliament on 11 July to demonstrate their disapproval of the ongoing court case by Swiss pharmaceutical company Novartis against the Indian government over its patent laws. As the case draws to a close, health organizations say a win for the pharmaceutical company will be a loss to the developing world, which sources the bulk of its generic medicines from India. full report
Other OCHA Sites